Use of the cytokine IP-10 as an anti-tumor agent
AssigneePresident and Fellows of Harvard College
InventorsPhilip Leder, Andrew Luster
Life of this patent
Estimating the term…
Abstract
Methods and therapeutic compositions for treating neoplasms by administration of the polypeptide IP-10, or a suitable DNA vector encoding the polypeptide IP-10.
Claims5
A method for inhibiting a neoplasm in a mammal, said method comprising administering to said mammal a neoplasm inhibiting amount of IP-10 polypeptide, wherein said IP10 polypeptide has the sequence of a naturally-occurring human or mouse IP-10 polypeptide, wherein said mammal is selected from the group consisting of a human and a mouse, and wherein said neoplasm is selected from the group consisting of a carcinoma, a leukemia, and a lymphoma.
Dependencies are inferred from the claim text.